Ryaltris Drug Interactions: 328 Major, 331 Moderate
Ryaltris (Olopatadine Hydrochloride And Mometasone Furoate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ryaltris. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Acarbose.
Level 1 evidence
Acenocoumarol
Mometasone furoate may increase the anticoagulant activities of Acenocoumarol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of adverse effects can be increased when Mometasone furoate is combined with Acetylsalicylic acid.
Level 1 evidence
Albendazole
The metabolism of Albendazole can be increased when combined with Mometasone furoate.
Level 2 evidence
Albuterol
The risk or severity of hypokalemia can be increased when Mometasone furoate is combined with Albuterol.
Level 2 evidence
Alfentanil
The metabolism of Alfentanil can be increased when combined with Mometasone furoate.
Level 2 evidence
Almasilate
The bioavailability of Mometasone furoate can be decreased when combined with Almasilate.
Level 2 evidence
Alogliptin
The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Alogliptin.
Level 1 evidence
Alprazolam
The metabolism of Alprazolam can be increased when combined with Mometasone furoate.
Level 2 evidence
Aluminium phosphate
The bioavailability of Mometasone furoate can be decreased when combined with Aluminium phosphate.
Level 2 evidence
Aluminum hydroxide
The bioavailability of Mometasone furoate can be decreased when combined with Aluminum hydroxide.
Level 2 evidence
Ambrisentan
The metabolism of Ambrisentan can be increased when combined with Mometasone furoate.
Level 2 evidence
Enter your NPI to unlock 56 major interactions for Ryaltris
Ryaltris (Olopatadine Hydrochloride And Mometasone Furoate) has 743 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ryaltris (Olopatadine Hydrochloride And Mometasone Furoate) has 328 major, 331 moderate, and 84 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ryaltris. Always confirm against the full prescribing information.